We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Substances that are classed as persistent organic pollutants (POPs) and when you're allowed to use them.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (9 April 2024) approved the medicine fosdenopterin (Nulibry) to treat the genetic disease Molybdenum Cofactor Deficiency (MoCD) Type A
Studied by X-ray absorption near-edge structure spectroscopy
How to label spirit drinks that you plan to sell in the UK.
Government response to the report by the Advisory Council on the Misuse of Drugs on xylazine, medetomidine and detomidine.
First published during the 2022 to 2024 Sunak Conservative government
It is economically feasible to use plant bioactive compounds in integrated vector management programmes
Between January and March 2024, HM Revenue and Customs (HMRC) issued compound settlement offers to 6 UK exporters totalling over £1.3 million.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).